BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31060282)

  • 1. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.
    Wang H; Li X; Zhangsun D; Yu G; Su R; Luo S
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31060282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hypersensitive effect of intramuscular administration of αO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain.
    Li X; Hu Y; Wu Y; Huang Y; Yu S; Ding Q; Zhangsun D; Luo S
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():112-119. PubMed ID: 26706456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2].
    Li Z; Han X; Hong X; Li X; Gao J; Zhang H; Zheng A
    Mar Drugs; 2021 Feb; 19(3):. PubMed ID: 33668830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
    Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
    Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
    Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
    Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
    Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Analgesic Effect of Venlafaxine and Its Mechanism on Oxaliplatin-Induced Neuropathic Pain in Mice.
    Li D; Lee JH; Choi CW; Kim J; Kim SK; Kim W
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
    Toyama S; Shimoyama N; Shimoyama M
    Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA[1,2] and GeXIVA[1,4].
    Xu P; Zhang P; Zhu X; Wu Y; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
    J Med Chem; 2023 Jul; 66(14):10092-10107. PubMed ID: 37464764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic Effects of Bee Venom Derived Phospholipase A(2) in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain.
    Li D; Lee Y; Kim W; Lee K; Bae H; Kim SK
    Toxins (Basel); 2015 Jun; 7(7):2422-34. PubMed ID: 26131771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats.
    Yoon H; Kim MJ; Yoon I; Li DX; Bae H; Kim SK
    Biol Pharm Bull; 2015; 38(5):710-4. PubMed ID: 25752933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
    Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
    BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
    Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.
    Sun Z; Bao J; Zhangsun M; Dong S; Zhangsun D; Luo S
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32272701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats.
    Aoki M; Mori A; Nakahara T; Sakamoto K; Ishii K
    Eur J Pharmacol; 2012 Dec; 696(1-3):62-9. PubMed ID: 23001015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of serum, enzyme, thiol, and forced degradation on the stabilities of αO-Conotoxin GeXIVA[1,2] and GeXIVA [1,4].
    Yu S; Wu Y; Xu P; Wang S; Zhangsun D; Luo S
    Chem Biol Drug Des; 2018 May; 91(5):1030-1041. PubMed ID: 29316361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats.
    Wala EP; Crooks PA; McIntosh JM; Holtman JR
    Anesth Analg; 2012 Sep; 115(3):713-20. PubMed ID: 22610850
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lee JH; Min D; Lee D; Kim W
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33494465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment.
    Zhu X; Yuan M; Wang H; Zhangsun D; Yu G; Che J; Luo S
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ɑO-Conotoxin GeXIVA isomers modulate N-type calcium (Ca
    Yousuf A; Wu X; Bony AR; Sadeghi M; Huang YH; Craik DJ; Adams DJ
    J Neurochem; 2022 Jan; 160(2):154-171. PubMed ID: 34738241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.